Sandbox:MDS: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 30: | Line 30: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Chronic myelomonocytic leukemia (CMML)'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''Chronic myelomonocytic leukemia (CMML)'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood. | :*Less than 20% myeloblasts in the bone marrow and greater than 1*109/L monocytes in peripheral blood. | ||
|} | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | |||
|valign=top| | |||
|+ | |||
! style="background: #4479BA; width: 250px; color: #FFFFFF;"|'''Old system''' | |||
! style="background: #4479BA; width: 600px; color: #FFFFFF;"|'''New system''' | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*Refractory cytopenia with unilineage dysplasia | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with ringed sideroblasts]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Refractory anemia with ring sideroblasts | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | || style="padding: 5px 5px; background: #F5F5F5;"|:*Refractory cytopenia with multilineage dysplasia | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Refractory anemias with excess blasts I and II | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Refractory anemia with excess blasts in transformation]] I–IV '''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*5q - syndrome | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Chronic myelomonocytic leukemia]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*Myelodysplastic-myeloproliferative overlap syndromes | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
| style="padding: 5px 5px; background: #F5F5F5;"| | |||
:*Refractory cytopenia of childhood | |||
|- | |||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
:*Unclassifiable myelodysplastic syndrome | |||
|} | |} |
Revision as of 14:35, 8 December 2015
Name | Description |
---|---|
Refractory anemia |
|
Refractory anemia with ring sideroblasts (RARS) |
|
Refractory anemia with excess blasts (RAEB) |
|
Refractory anemia with excess blasts in transformation (RAEB-T) |
|
Chronic myelomonocytic leukemia (CMML) |
|
Old system | New system |
---|---|
Refractory anemia |
|
Refractory anemia with ringed sideroblasts |
|
:*Refractory cytopenia with multilineage dysplasia | |
Refractory anemia with excess blasts |
|
Refractory anemia with excess blasts in transformation I–IV |
|
Chronic myelomonocytic leukemia |
|
| |
|